This K07 proposal will provide me with the experience that I need to become a leading independent investigator of diet and cancer survival. My objective is to elucidate the role of diet after cancer diagnosis and develop interventions to improve cancer survivorship care. I have a solid foundation in nutrition and cancer epidemiology. My proposed 5-year training plan builds on this foundation and provides me with training in: 1) randomized controlled trial (RCT) design and management; 3) the biology, clinical management, and epidemiology of CRC; and 3) the use of mobile technology in lifestyle interventions. My proposed research will provide me with practical knowledge, skills, and experience in these areas, and fill important gaps in the scientific literature regarding the role of diet after CRC diagnosis. Over one million Americans are living with a diagnosis of CRC. While limited, data suggest that diet after CRC diagnosis impacts survival. Among stage III CRC survivors, a western dietary pattern was associated with a 3- fold increased risk of CRC recurrence or death. Based on this evidence of harm from a Western diet, there is a need for dietary interventions for CRC survivors. No study has pilot tested an intervention using mobile technology to improve diet after CRC. Thus, in Aim 1, I will conduct a pilot RCT to determine the feasibility and acceptability of a diet intervention targeted at reducing intake of a Western diet using mobile technology among CRC survivors. The intervention will target reduced intake of red and processed meat, alcohol, and sugar sweetened beverages and increased intake of whole grains, vegetables, and fruits. The results of this aim will provide preliminary data for an R01 application to conduct a definitive RCT testing the impact of improving diet on biological and clinical endpoints in CRC survivors. In addition, preclinical studies suggest that vegetable fats, which are not a characteristic of a Western diet, inhibit CRC progression. No prior study has examined vegetable fat intake after CRC diagnosis and survival in humans.
In Aim 2, I will use data from two RCTs of adjuvant chemotherapy among 2,372 CRC patients to determine whether consumption of vegetable fats after CRC diagnosis is associated with lower risk of CRC-specific and overall survival. I will apply the results of these analyses to refine the dietary intervention before moving forward to a large-scale RCT in my future work. My training and research plan incorporates coursework, mentoring, group meetings, seminars, journal clubs, conferences, and practical experience in a leading academic institution, the University of California, San Francisco. My research plan fits well in the program of my primary mentor, Dr. Alan Venook, who will oversee my training, research, and career development. I have assembled a strong mentoring team with expertise in RCTs, gastrointestinal oncology, the use of mobile technology in lifestyle interventions, and grant writing. This K07 proposal will accelerate my transition to an independent investigator dedicated to elucidating the role of diet in cancer survival.

Public Health Relevance

This K07 application will provide me with the training and research experiences that I need to transition to a leading independent investigator of the role of diet in cancer survival. My proposed 5-year training and research plan build on my solid foundation in nutrition and cancer epidemiology and will provide me with training on: 1) randomized controlled trials; 2) the biology, clinical management, and epidemiology of colorectal cancer; and 3) the use of mobile technology in lifestyle interventions. In my proposed research, I will pilot test an intervention using mobile technology to improve the diet of colorectal cancer survivors and will examine the impact of vegetable fat intake after diagnosis of colorectal cancer on colorectal cancer-specific and overall survival; these projects will provide strong preliminary data for the development and funding of my future independent research program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
5K07CA197077-03
Application #
9514041
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Perkins, Susan N
Project Start
2016-07-01
Project End
2021-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Bauer, Scott R; Van Blarigan, Erin L; Stampfer, Meir J et al. (2018) Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study. Prostate 78:202-212
Van Blarigan, Erin L; Fuchs, Charles S; Niedzwiecki, Donna et al. (2018) Marine ?-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev 27:438-445
Van Blarigan, Erin L; Ou, Fang-Shu; Niedzwiecki, Donna et al. (2018) Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev 27:1227-1230
Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSUREā„¢). Prostate 78:32-39
Peisch, Sam F; Van Blarigan, Erin L; Chan, June M et al. (2017) Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol 35:867-874
Emami, Nima C; Leong, Lancelote; Wan, Eunice et al. (2017) Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate 77:425-434
Van Blarigan, Erin L; Kenfield, Stacey A; Tantum, Lucy et al. (2017) The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer 3:e5